View Single Post
Old 02-22-2017, 02:31 PM   #141
Breeze
Grizzled Veteran
 
Join Date: Oct 2002
Location: Northern Suburbs of ATL
February 22, 2017

Just got a text from my coordinator to inform me that the keytruda (immunotherapy) drug has some new safety warnings. Apparently, taking the drug can lead to Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis (that's not a pretty thing) and immune mediated myocarditis.

I'm pretty sure the myocarditis warning is due to 2 Optiva patients that died following their initial treatment with that drug, and given Keytruda is also a cancer immunotherapy drug the warning was added to it as well.

I'll continue on with the trial even with these new potential side-effects, because ultimately I figure it is worth the risk. Plus most of these new problems are reported about 14 days after the first dose, and I'll be having my 7th in a couple of weeks. Just one more thing that I need to pray about...
Breeze is offline   Reply With Quote